25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Hefei Lifeon Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyze Hefei Lifeon Pharmaceutical Co Ltd together

I guess you are interested in Hefei Lifeon Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hefei Lifeon Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Hefei Lifeon Pharmaceutical Co Ltd

I send you an email if I find something interesting about Hefei Lifeon Pharmaceutical Co Ltd.

1. Quick Overview

1.1. Quick analysis of Hefei Lifeon Pharmaceutical Co Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Hefei Lifeon Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.00
When do you have the money?
1 year
How often do you get paid?
61.9%

What is your share worth?

Current worth
¥10.05
Expected worth in 1 year
¥10.94
How sure are you?
85.7%

+ What do you gain per year?

Total Gains per Share
¥0.90
Return On Investment
4.7%

For what price can you sell your share?

Current Price per Share
¥18.97
Expected price per share
¥17.21 - ¥21.77
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Hefei Lifeon Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)
¥18.97
Intrinsic Value Per Share
¥2.61 - ¥3.35
Total Value Per Share
¥12.65 - ¥13.40

2.2. Growth of Hefei Lifeon Pharmaceutical Co Ltd (5 min.)




Is Hefei Lifeon Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$265.9m$219.2m$42.8m16.3%

How much money is Hefei Lifeon Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$6m$7.2m-$1.2m-20.7%
Net Profit Margin11.6%10.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Hefei Lifeon Pharmaceutical Co Ltd (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Hefei Lifeon Pharmaceutical Co Ltd?

Welcome investor! Hefei Lifeon Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Hefei Lifeon Pharmaceutical Co Ltd.

First you should know what it really means to hold a share of Hefei Lifeon Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Hefei Lifeon Pharmaceutical Co Ltd is ¥18.97. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hefei Lifeon Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hefei Lifeon Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥10.05. Based on the TTM, the Book Value Change Per Share is ¥0.22 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.44 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hefei Lifeon Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.030.2%0.030.2%0.040.2%0.030.2%0.030.2%
Usd Book Value Change Per Share0.030.2%0.030.2%0.060.3%0.070.4%0.070.3%
Usd Dividend Per Share0.000.0%0.000.0%0.030.2%0.010.1%0.010.1%
Usd Total Gains Per Share0.030.2%0.030.2%0.090.5%0.080.4%0.080.4%
Usd Price Per Share2.77-3.03-4.82-3.76-3.58-
Price to Earnings Ratio23.07-24.90-32.69-28.35-27.00-
Price-to-Total Gains Ratio83.19-31.30-59.10--92.81--92.81-
Price to Book Ratio1.99-2.22-4.24-3.67-3.49-
Price-to-Total Gains Ratio83.19-31.30-59.10--92.81--92.81-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.621654
Number of shares381
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.030.07
Usd Total Gains Per Share0.030.08
Gains per Quarter (381 shares)11.8030.26
Gains per Year (381 shares)47.19121.03
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10473715106111
20948430212232
3114113146317353
4118817861423474
5123522576529595
6128227291635716
71329319107741837
82376366122846958
924234131379521079
10247046015210581200

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%21.00.00.0100.0%21.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%16.03.01.080.0%16.03.02.076.2%16.03.02.076.2%
Dividend per Share2.00.02.050.0%7.00.05.058.3%12.00.08.060.0%13.00.08.061.9%13.00.08.061.9%
Total Gains per Share3.01.00.075.0%10.02.00.083.3%17.03.00.085.0%18.03.00.085.7%18.03.00.085.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Hefei Lifeon Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2390.223+7%0.440-46%0.502-52%0.478-50%
Book Value Per Share--10.0479.899+1%8.295+21%6.967+44%6.635+51%
Current Ratio--2.1532.123+1%2.440-12%2.515-14%2.395-10%
Debt To Asset Ratio--0.2470.243+2%0.261-5%0.281-12%0.267-8%
Debt To Equity Ratio--0.3640.356+2%0.366-1%0.406-10%0.387-6%
Dividend Per Share--0.0020.001+96%0.242-99%0.072-97%0.069-97%
Enterprise Value--3203187781.2703593726138.470-11%6414470252.700-50%6379790188.094-50%6379790188.094-50%
Eps--0.2170.227-5%0.275-21%0.233-7%0.228-5%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--2.2512.427-7%3.297-32%3.103-27%3.103-27%
Free Cash Flow Per Share--0.1880.138+36%-0.280+249%-0.031+117%-0.029+115%
Free Cash Flow To Equity Per Share--0.1880.138+36%-0.223+219%0.060+212%0.064+196%
Gross Profit Margin--1.0001.0000%-0.645+164%-1.192+219%-1.259+226%
Intrinsic Value_10Y_max--3.354--------
Intrinsic Value_10Y_min--2.607--------
Intrinsic Value_1Y_max---0.366--------
Intrinsic Value_1Y_min---0.359--------
Intrinsic Value_3Y_max---0.564--------
Intrinsic Value_3Y_min---0.549--------
Intrinsic Value_5Y_max---0.117--------
Intrinsic Value_5Y_min---0.155--------
Market Cap3628202200.000-6%3833350977.6304201438699.978-9%6666840668.500-43%5205031243.696-26%4957172613.043-23%
Net Profit Margin--0.1170.116+1%0.109+7%0.091+28%0.090+30%
Operating Margin----0%0.099-100%0.051-100%0.052-100%
Operating Ratio--1.2221.168+5%1.103+11%1.005+22%1.001+22%
Pb Ratio1.888-5%1.9922.218-10%4.236-53%3.668-46%3.493-43%
Pe Ratio21.867-5%23.06524.903-7%32.690-29%28.349-19%26.999-15%
Price Per Share18.970-5%20.01021.930-9%34.857-43%27.207-26%25.911-23%
Price To Free Cash Flow Ratio25.218-5%26.60116.792+58%-55.751+310%-34.426+229%-32.787+223%
Price To Total Gains Ratio78.866-5%83.19031.298+166%59.104+41%-92.810+212%-92.810+212%
Quick Ratio--0.9760.920+6%1.602-39%1.646-41%1.567-38%
Return On Assets--0.0160.017-7%0.025-34%0.026-37%0.024-33%
Return On Equity--0.0240.026-6%0.034-29%0.037-35%0.035-32%
Total Gains Per Share--0.2410.224+7%0.682-65%0.575-58%0.547-56%
Usd Book Value--265988118.342262093894.142+1%219245607.752+21%184233037.980+44%175460036.171+52%
Usd Book Value Change Per Share--0.0330.031+7%0.061-46%0.069-52%0.066-50%
Usd Book Value Per Share--1.3881.368+1%1.146+21%0.963+44%0.917+51%
Usd Dividend Per Share--0.0000.000+96%0.033-99%0.010-97%0.010-97%
Usd Enterprise Value--442680551.372496652952.337-11%886479788.923-50%881687003.995-50%881687003.995-50%
Usd Eps--0.0300.031-5%0.038-21%0.032-7%0.032-5%
Usd Free Cash Flow--4978857.7843650910.280+36%-7410039.060+249%-829019.071+117%-767612.926+115%
Usd Free Cash Flow Per Share--0.0260.019+36%-0.039+249%-0.004+117%-0.004+115%
Usd Free Cash Flow To Equity Per Share--0.0260.019+36%-0.031+219%0.008+212%0.009+196%
Usd Market Cap501417544.040-6%529769105.108580638828.337-9%921357380.387-43%719335317.879-26%685081255.123-23%
Usd Price Per Share2.622-5%2.7653.031-9%4.817-43%3.760-26%3.581-23%
Usd Profit--5742049.3236021279.153-5%7270469.856-21%6155514.352-7%6034175.369-5%
Usd Revenue--49169250.07151873471.147-5%76343559.568-36%70624904.614-30%70014623.182-30%
Usd Total Gains Per Share--0.0330.031+7%0.094-65%0.079-58%0.076-56%
 EOD+4 -4MRQTTM+21 -16YOY+16 -235Y+16 -2310Y+16 -23

3.3 Fundamental Score

Let's check the fundamental score of Hefei Lifeon Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1521.867
Price to Book Ratio (EOD)Between0-11.888
Net Profit Margin (MRQ)Greater than00.117
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.976
Current Ratio (MRQ)Greater than12.153
Debt to Asset Ratio (MRQ)Less than10.247
Debt to Equity Ratio (MRQ)Less than10.364
Return on Equity (MRQ)Greater than0.150.024
Return on Assets (MRQ)Greater than0.050.016
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Hefei Lifeon Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose18.460
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Hefei Lifeon Pharmaceutical Co Ltd

Hefei Lifeon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients. It operates through Pharmaceutical Industry, Pharmaceutical Wholesale and Distribution, and Pharmaceutical Retail Business segments. The company offers active pharmaceutical ingredients, which include nifedipine, paliperidone, prilocaine, methylphenidate hydrochloride, dimercaptosuccinic acid, doxazosin mesylate, paeonol, urea, felodipine, and troxerutin; and medical preparations, such as osmotic pump preparations, central nervous systems, Chinese patent medicines, eye drops, external use, and general oral medicines. In addition, it provides medical intermediates, including 3-methoxy-1 propanethiol, mercaptosuccinic acid, domiphene, sodium dimercaptosulfonate, 3-mercapto-1-propanol, paeonol, sodium paeonol sulfonate, methyl 2,3-dichlorobenzylidene acetoacetate, n-[(1,4-benzodioxan-2-yl) carbonyl piperazine hydrochloride, alogliptin benzoate, roflumilast, and zofenopril calcium; plant extract products, such as clove oil and campanula extracts; and pieces that consist of poria decoction, astragalus, honeysuckle, rose, and phellinus decoction. Further, the company offers central nervous system drugs, cardiovascular drugs, digestive system drugs, ophthalmic drugs, external skin drugs and other fields. Hefei Lifeon Pharmaceutical Co., Ltd. was founded in 2002 and is headquartered in Hefei, China.

Fundamental data was last updated by Penke on 2025-03-09 05:57:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Hefei Lifeon Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Hefei Lifeon Pharmaceutical Co Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 11.7% means that ¥0.12 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hefei Lifeon Pharmaceutical Co Ltd:

  • The MRQ is 11.7%. The company is making a huge profit. +2
  • The TTM is 11.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ11.7%TTM11.6%+0.1%
TTM11.6%YOY10.9%+0.6%
TTM11.6%5Y9.1%+2.5%
5Y9.1%10Y9.0%+0.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.7%-99.7%+111.4%
TTM11.6%-203.8%+215.4%
YOY10.9%-199.6%+210.5%
5Y9.1%-328.9%+338.0%
10Y9.0%-481.7%+490.7%
4.3.1.2. Return on Assets

Shows how efficient Hefei Lifeon Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hefei Lifeon Pharmaceutical Co Ltd to the Biotechnology industry mean.
  • 1.6% Return on Assets means that Hefei Lifeon Pharmaceutical Co Ltd generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hefei Lifeon Pharmaceutical Co Ltd:

  • The MRQ is 1.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.7%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.6%TTM1.7%-0.1%
TTM1.7%YOY2.5%-0.7%
TTM1.7%5Y2.6%-0.8%
5Y2.6%10Y2.4%+0.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6%-12.5%+14.1%
TTM1.7%-12.3%+14.0%
YOY2.5%-11.8%+14.3%
5Y2.6%-13.2%+15.8%
10Y2.4%-15.1%+17.5%
4.3.1.3. Return on Equity

Shows how efficient Hefei Lifeon Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hefei Lifeon Pharmaceutical Co Ltd to the Biotechnology industry mean.
  • 2.4% Return on Equity means Hefei Lifeon Pharmaceutical Co Ltd generated ¥0.02 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hefei Lifeon Pharmaceutical Co Ltd:

  • The MRQ is 2.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.6%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.4%TTM2.6%-0.2%
TTM2.6%YOY3.4%-0.8%
TTM2.6%5Y3.7%-1.1%
5Y3.7%10Y3.5%+0.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4%-15.9%+18.3%
TTM2.6%-16.6%+19.2%
YOY3.4%-15.2%+18.6%
5Y3.7%-18.9%+22.6%
10Y3.5%-20.4%+23.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Hefei Lifeon Pharmaceutical Co Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Hefei Lifeon Pharmaceutical Co Ltd is operating .

  • Measures how much profit Hefei Lifeon Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hefei Lifeon Pharmaceutical Co Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hefei Lifeon Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY9.9%-9.9%
TTM-5Y5.1%-5.1%
5Y5.1%10Y5.2%-0.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--208.0%+208.0%
TTM--308.8%+308.8%
YOY9.9%-208.2%+218.1%
5Y5.1%-367.6%+372.7%
10Y5.2%-480.4%+485.6%
4.3.2.2. Operating Ratio

Measures how efficient Hefei Lifeon Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.22 means that the operating costs are ¥1.22 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Hefei Lifeon Pharmaceutical Co Ltd:

  • The MRQ is 1.222. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.168. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.222TTM1.168+0.055
TTM1.168YOY1.103+0.065
TTM1.1685Y1.005+0.163
5Y1.00510Y1.001+0.004
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2222.117-0.895
TTM1.1683.151-1.983
YOY1.1033.190-2.087
5Y1.0054.701-3.696
10Y1.0016.433-5.432
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Hefei Lifeon Pharmaceutical Co Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Hefei Lifeon Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.15 means the company has ¥2.15 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Hefei Lifeon Pharmaceutical Co Ltd:

  • The MRQ is 2.153. The company is able to pay all its short-term debts. +1
  • The TTM is 2.123. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.153TTM2.123+0.031
TTM2.123YOY2.440-0.318
TTM2.1235Y2.515-0.392
5Y2.51510Y2.395+0.120
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1533.609-1.456
TTM2.1233.858-1.735
YOY2.4404.488-2.048
5Y2.5155.973-3.458
10Y2.3956.280-3.885
4.4.3.2. Quick Ratio

Measures if Hefei Lifeon Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hefei Lifeon Pharmaceutical Co Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 0.98 means the company can pay off ¥0.98 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hefei Lifeon Pharmaceutical Co Ltd:

  • The MRQ is 0.976. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.920. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.976TTM0.920+0.056
TTM0.920YOY1.602-0.682
TTM0.9205Y1.646-0.726
5Y1.64610Y1.567+0.078
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9763.024-2.048
TTM0.9203.308-2.388
YOY1.6024.370-2.768
5Y1.6465.954-4.308
10Y1.5676.492-4.925
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Hefei Lifeon Pharmaceutical Co Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Hefei Lifeon Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hefei Lifeon Pharmaceutical Co Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.25 means that Hefei Lifeon Pharmaceutical Co Ltd assets are financed with 24.7% credit (debt) and the remaining percentage (100% - 24.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hefei Lifeon Pharmaceutical Co Ltd:

  • The MRQ is 0.247. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.243. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.247TTM0.243+0.004
TTM0.243YOY0.261-0.018
TTM0.2435Y0.281-0.038
5Y0.28110Y0.267+0.013
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2470.341-0.094
TTM0.2430.342-0.099
YOY0.2610.310-0.049
5Y0.2810.363-0.082
10Y0.2670.384-0.117
4.5.4.2. Debt to Equity Ratio

Measures if Hefei Lifeon Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hefei Lifeon Pharmaceutical Co Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 36.4% means that company has ¥0.36 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hefei Lifeon Pharmaceutical Co Ltd:

  • The MRQ is 0.364. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.356. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.364TTM0.356+0.008
TTM0.356YOY0.366-0.010
TTM0.3565Y0.406-0.050
5Y0.40610Y0.387+0.019
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3640.387-0.023
TTM0.3560.430-0.074
YOY0.3660.391-0.025
5Y0.4060.451-0.045
10Y0.3870.495-0.108
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Hefei Lifeon Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Hefei Lifeon Pharmaceutical Co Ltd to the Biotechnology industry mean.
  • A PE ratio of 23.07 means the investor is paying ¥23.07 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hefei Lifeon Pharmaceutical Co Ltd:

  • The EOD is 21.867. Based on the earnings, the company is fair priced.
  • The MRQ is 23.065. Based on the earnings, the company is fair priced.
  • The TTM is 24.903. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD21.867MRQ23.065-1.199
MRQ23.065TTM24.903-1.837
TTM24.903YOY32.690-7.788
TTM24.9035Y28.349-3.447
5Y28.34910Y26.999+1.350
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD21.867-2.175+24.042
MRQ23.065-2.706+25.771
TTM24.903-3.275+28.178
YOY32.690-3.402+36.092
5Y28.349-6.326+34.675
10Y26.999-6.808+33.807
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hefei Lifeon Pharmaceutical Co Ltd:

  • The EOD is 25.218. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 26.601. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 16.792. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD25.218MRQ26.601-1.383
MRQ26.601TTM16.792+9.809
TTM16.792YOY-55.751+72.542
TTM16.7925Y-34.426+51.218
5Y-34.42610Y-32.787-1.639
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD25.218-2.977+28.195
MRQ26.601-3.670+30.271
TTM16.792-3.936+20.728
YOY-55.751-4.315-51.436
5Y-34.426-8.475-25.951
10Y-32.787-9.317-23.470
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Hefei Lifeon Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.99 means the investor is paying ¥1.99 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Hefei Lifeon Pharmaceutical Co Ltd:

  • The EOD is 1.888. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.992. Based on the equity, the company is underpriced. +1
  • The TTM is 2.218. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.888MRQ1.992-0.104
MRQ1.992TTM2.218-0.226
TTM2.218YOY4.236-2.018
TTM2.2185Y3.668-1.450
5Y3.66810Y3.493+0.175
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.8881.892-0.004
MRQ1.9922.177-0.185
TTM2.2182.392-0.174
YOY4.2362.461+1.775
5Y3.6683.815-0.147
10Y3.4934.539-1.046
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,554,824
Total Liabilities630,163
Total Stockholder Equity1,731,705
 As reported
Total Liabilities 630,163
Total Stockholder Equity+ 1,731,705
Total Assets = 2,554,824

Assets

Total Assets2,554,824
Total Current Assets1,158,018
Long-term Assets1,396,806
Total Current Assets
Cash And Cash Equivalents 319,783
Short-term Investments 167,864
Net Receivables 357,147
Inventory 209,907
Other Current Assets 18,165
Total Current Assets  (as reported)1,158,018
Total Current Assets  (calculated)1,072,865
+/- 85,153
Long-term Assets
Property Plant Equipment 944,862
Goodwill 74,441
Intangible Assets 109,371
Long-term Assets Other 22,326
Long-term Assets  (as reported)1,396,806
Long-term Assets  (calculated)1,151,001
+/- 245,805

Liabilities & Shareholders' Equity

Total Current Liabilities537,804
Long-term Liabilities92,359
Total Stockholder Equity1,731,705
Total Current Liabilities
Accounts payable 328,118
Other Current Liabilities 1,862
Total Current Liabilities  (as reported)537,804
Total Current Liabilities  (calculated)329,980
+/- 207,824
Long-term Liabilities
Long term Debt 59,647
Capital Lease Obligations Min Short Term Debt2,121
Long-term Liabilities  (as reported)92,359
Long-term Liabilities  (calculated)61,768
+/- 30,592
Total Stockholder Equity
Retained Earnings 947,902
Total Stockholder Equity (as reported)1,731,705
Total Stockholder Equity (calculated)947,902
+/- 783,803
Other
Capital Stock191,572
Common Stock Shares Outstanding 191,572
Net Invested Capital 1,791,352
Net Working Capital 620,215
Property Plant and Equipment Gross 944,862



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
> Total Assets 
901,121
0
889,813
0
943,846
1,079,822
1,536,020
1,659,459
1,613,793
1,770,187
1,674,445
1,899,969
1,962,221
2,125,342
2,121,756
2,306,025
1,959,349
2,217,151
2,483,680
2,494,373
2,483,905
2,554,824
2,554,8242,483,9052,494,3732,483,6802,217,1511,959,3492,306,0252,121,7562,125,3421,962,2211,899,9691,674,4451,770,1871,613,7931,659,4591,536,0201,079,822943,8460889,8130901,121
   > Total Current Assets 
717,854
0
694,829
0
736,550
858,094
1,291,961
1,364,465
1,250,093
1,354,569
1,219,648
1,425,204
1,422,630
1,536,073
1,452,547
1,557,043
1,072,710
1,073,366
1,151,147
1,139,856
1,091,197
1,158,018
1,158,0181,091,1971,139,8561,151,1471,073,3661,072,7101,557,0431,452,5471,536,0731,422,6301,425,2041,219,6481,354,5691,250,0931,364,4651,291,961858,094736,5500694,8290717,854
       Cash And Cash Equivalents 
146,298
0
223,244
0
247,463
290,601
766,586
169,517
174,331
245,457
654,254
180,099
272,484
323,723
642,580
296,244
236,539
202,708
502,929
187,746
267,767
319,783
319,783267,767187,746502,929202,708236,539296,244642,580323,723272,484180,099654,254245,457174,331169,517766,586290,601247,4630223,2440146,298
       Short-term Investments 
0
0
0
0
0
0
0
550,000
476,303
401,251
133
440,121
402,561
340,962
115
310,112
326,486
266,482
61,520
322,492
157,899
167,864
167,864157,899322,49261,520266,482326,486310,112115340,962402,561440,121133401,251476,303550,0000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
415,430
368,127
460,809
320,921
465,767
303,033
303,681
258,447
282,188
354,611
357,147
357,147354,611282,188258,447303,681303,033465,767320,921460,809368,127415,43000000000000
       Inventory 
219,013
0
179,167
0
184,346
193,854
193,800
216,225
219,360
217,968
188,857
273,629
264,735
321,398
361,765
373,038
172,736
258,715
242,914
231,137
220,410
209,907
209,907220,410231,137242,914258,715172,736373,038361,765321,398264,735273,629188,857217,968219,360216,225193,800193,854184,3460179,1670219,013
       Other Current Assets 
352,543
0
292,418
0
304,742
373,639
331,576
428,722
380,099
489,892
376,404
1,199
1,512
4,686
9,960
13,295
33,916
41,780
19,265
21,890
20,310
18,165
18,16520,31021,89019,26541,78033,91613,2959,9604,6861,5121,199376,404489,892380,099428,722331,576373,639304,7420292,4180352,543
   > Long-term Assets 
183,267
0
194,985
0
207,295
221,728
244,058
294,994
363,700
415,618
454,797
474,765
539,591
589,269
669,209
748,982
886,639
1,143,785
1,332,533
1,354,516
1,392,708
1,396,806
1,396,8061,392,7081,354,5161,332,5331,143,785886,639748,982669,209589,269539,591474,765454,797415,618363,700294,994244,058221,728207,2950194,9850183,267
       Property Plant Equipment 
137,951
0
146,097
0
160,369
174,486
199,033
220,348
255,994
263,229
299,030
304,526
391,813
448,350
538,117
569,341
589,395
738,045
896,216
909,007
933,996
944,862
944,862933,996909,007896,216738,045589,395569,341538,117448,350391,813304,526299,030263,229255,994220,348199,033174,486160,3690146,0970137,951
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
73,527
74,441
74,441
74,441
74,441
74,44174,44174,44174,44173,52700000000000000000
       Intangible Assets 
32,135
0
31,510
0
31,796
31,712
31,420
38,718
38,833
91,016
90,244
88,696
86,614
85,640
84,768
83,485
77,410
103,777
115,369
113,780
111,590
109,371
109,371111,590113,780115,369103,77777,41083,48584,76885,64086,61488,69690,24491,01638,83338,71831,42031,71231,796031,510032,135
       Long-term Assets Other 
8,718
0
13,033
0
10,722
11,075
10,232
562,201
521,390
440,612
39,090
496,346
437,937
373,663
37,384
85,319
15,465
16,779
16,642
21,979
38,149
22,326
22,32638,14921,97916,64216,77915,46585,31937,384373,663437,937496,34639,090440,612521,390562,20110,23211,07510,722013,03308,718
> Total Liabilities 
365,435
0
299,815
0
315,593
417,953
362,026
443,774
402,535
517,171
370,534
548,931
624,988
711,470
641,535
753,234
397,462
466,302
610,182
585,546
604,960
630,163
630,163604,960585,546610,182466,302397,462753,234641,535711,470624,988548,931370,534517,171402,535443,774362,026417,953315,5930299,8150365,435
   > Total Current Liabilities 
348,312
0
281,418
0
295,134
397,826
342,348
407,623
353,435
468,905
328,054
508,971
570,364
649,381
622,628
736,124
375,541
436,860
542,729
520,365
538,581
537,804
537,804538,581520,365542,729436,860375,541736,124622,628649,381570,364508,971328,054468,905353,435407,623342,348397,826295,1340281,4180348,312
       Short-term Debt 
24,000
0
24,041
0
0
0
0
0
0
0
0
0
7,582
0
10,033
51,579
0
0
0
0
0
0
00000051,57910,03307,58200000000024,041024,000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
41,994
0
0
0
0
0
0
00000041,994000000000000000
       Accounts payable 
282,417
0
200,349
0
254,064
334,508
280,278
357,782
301,177
407,654
242,929
440,782
486,769
532,942
460,655
546,252
234,800
290,069
301,251
308,243
340,436
328,118
328,118340,436308,243301,251290,069234,800546,252460,655532,942486,769440,782242,929407,654301,177357,782280,278334,508254,0640200,3490282,417
       Other Current Liabilities 
33,524
0
49,146
0
30,813
47,082
53,769
41,249
40,732
45,734
85,125
68,189
76,012
116,439
151,940
138,293
81,216
116,914
1,506
1,993
1,450
1,862
1,8621,4501,9931,506116,91481,216138,293151,940116,43976,01268,18985,12545,73440,73241,24953,76947,08230,813049,146033,524
   > Long-term Liabilities 
17,123
0
18,397
0
20,459
20,128
19,678
36,151
49,100
48,266
42,480
39,961
54,624
62,089
18,907
17,109
21,921
29,442
67,452
65,180
66,379
92,359
92,35966,37965,18067,45229,44221,92117,10918,90762,08954,62439,96142,48048,26649,10036,15119,67820,12820,459018,397017,123
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
43,569
15,527
15,062
17,424
26,284
0
0
0
0
000026,28417,42415,06215,52743,5690000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
7,698
7,614
6,747
6,615
7,615
0
0
0
0
00007,6156,6156,7477,6147,6980000000000000
> Total Stockholder Equity
535,686
0
589,998
0
628,253
661,869
1,173,993
1,215,684
1,211,258
1,253,016
1,303,911
1,351,038
1,337,233
1,413,872
1,480,221
1,552,792
1,561,887
1,604,748
1,685,526
1,714,931
1,692,406
1,731,705
1,731,7051,692,4061,714,9311,685,5261,604,7481,561,8871,552,7921,480,2211,413,8721,337,2331,351,0381,303,9111,253,0161,211,2581,215,6841,173,993661,869628,2530589,9980535,686
   Common Stock
69,480
0
69,480
0
69,480
69,480
92,640
92,640
92,640
92,640
92,640
92,640
120,432
122,467
122,467
122,467
159,207
159,675
0
0
0
0
0000159,675159,207122,467122,467122,467120,43292,64092,64092,64092,64092,64092,64069,48069,480069,480069,480
   Retained Earnings 
360,762
0
414,995
0
453,250
486,866
511,105
552,796
548,369
590,127
636,647
683,774
669,969
742,348
766,493
832,635
899,762
936,364
912,969
938,608
910,579
947,902
947,902910,579938,608912,969936,364899,762832,635766,493742,348669,969683,774636,647590,127548,369552,796511,105486,866453,2500414,9950360,762
   Capital Surplus 0000000000000000000000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 
105,444
0
105,523
0
105,523
105,523
570,248
570,248
570,248
570,248
574,624
574,624
546,832
549,057
591,261
597,690
0
0
0
0
0
0
000000597,690591,261549,057546,832574,624574,624570,248570,248570,248570,248105,523105,5230105,5230105,444



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,900,789
Cost of Revenue-922,202
Gross Profit978,587978,587
 
Operating Income (+$)
Gross Profit978,587
Operating Expense-1,665,307
Operating Income235,482-686,720
 
Operating Expense (+$)
Research Development84,956
Selling General Administrative556,470
Selling And Marketing Expenses0
Operating Expense1,665,307641,425
 
Net Interest Income (+$)
Interest Income4,651
Interest Expense-1,281
Other Finance Cost-119
Net Interest Income3,251
 
Pretax Income (+$)
Operating Income235,482
Net Interest Income3,251
Other Non-Operating Income Expenses0
Income Before Tax (EBT)257,417235,482
EBIT - interestExpense = -1,281
226,673
227,954
Interest Expense1,281
Earnings Before Interest and Taxes (EBIT)0258,698
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax257,417
Tax Provision-23,534
Net Income From Continuing Ops233,883233,883
Net Income226,673
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-3,251
 

Technical Analysis of Hefei Lifeon Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hefei Lifeon Pharmaceutical Co Ltd. The general trend of Hefei Lifeon Pharmaceutical Co Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hefei Lifeon Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hefei Lifeon Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 19.95 < 20.77 < 21.77.

The bearish price targets are: 18.44 > 17.25 > 17.21.

Tweet this
Hefei Lifeon Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hefei Lifeon Pharmaceutical Co Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hefei Lifeon Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hefei Lifeon Pharmaceutical Co Ltd.

Hefei Lifeon Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartHefei Lifeon Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hefei Lifeon Pharmaceutical Co Ltd. The current adx is .

Hefei Lifeon Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hefei Lifeon Pharmaceutical Co Ltd.

Hefei Lifeon Pharmaceutical Co Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hefei Lifeon Pharmaceutical Co Ltd.

Hefei Lifeon Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartHefei Lifeon Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hefei Lifeon Pharmaceutical Co Ltd.

Hefei Lifeon Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartHefei Lifeon Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hefei Lifeon Pharmaceutical Co Ltd.

Hefei Lifeon Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartHefei Lifeon Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hefei Lifeon Pharmaceutical Co Ltd.

Hefei Lifeon Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartHefei Lifeon Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hefei Lifeon Pharmaceutical Co Ltd.

Hefei Lifeon Pharmaceutical Co Ltd Daily Williams %R ChartHefei Lifeon Pharmaceutical Co Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hefei Lifeon Pharmaceutical Co Ltd.

Hefei Lifeon Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hefei Lifeon Pharmaceutical Co Ltd.

Hefei Lifeon Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartHefei Lifeon Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hefei Lifeon Pharmaceutical Co Ltd.

Hefei Lifeon Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartHefei Lifeon Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hefei Lifeon Pharmaceutical Co Ltd.

Hefei Lifeon Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartHefei Lifeon Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hefei Lifeon Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-10-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-12STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-14STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-12-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-31STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-01-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-03BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-05STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Hefei Lifeon Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hefei Lifeon Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose18.460
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Hefei Lifeon Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Hefei Lifeon Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hefei Lifeon Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hefei Lifeon Pharmaceutical Co Ltd

I send you an email if I find something interesting about Hefei Lifeon Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Hefei Lifeon Pharmaceutical Co Ltd.

Receive notifications about Hefei Lifeon Pharmaceutical Co Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.